Results 151 to 160 of about 40,829 (218)

Molecular Characterization and Pathogenicity Evaluation of a H1N1 Subtype Swine Influenza Virus

The Pakistan Veterinary Journal
openaire   +1 more source

Whole-genome analysis of influenza A(H1N1)pdm09 viruses in Cameroon (2019-2024) using nanopore sequencing. [PDF]

BMC Infect Dis
Tsafack DT, Monamele CG, Koro Koro F, Essengue LLM, Mounchili-Njifon A, Esso L, Njankouo Ripa M, Touoyem PI, Mouliem JLM, Tamoufe U, Moumbeket-Yifomnjou MH, Njouom R.   +11 more
europepmc   +1 more source

Changing Epidemiology of Influenza Infections Among Children in the Post-Pandemic Period: A Case Study in Xi'an, China. [PDF]

Vaccines (Basel)
Zhao Z, Lan N, Chen Y, Yang J, Bai J, Liu J.   +5 more
europepmc   +1 more source

Highly Conserved Influenza A Nucleoprotein as a Target for Broad-Spectrum Intervention: Characterization of a Monoclonal Antibody with Pan-Influenza Reactivity. [PDF]

Vet Sci
Liu J, Gao W, Zhao K, Huang Z, Liu L, Chang J, Cao X, Zhou W, Zhou X, Liu Y, Li X, Song Y.   +11 more
europepmc   +1 more source

Elicitation of Protective Immune Responses Against Influenza Virus Following Intranasal Delivery of Fluzone or Flublok Vaccines. [PDF]

Vaccines (Basel)
Uno N, Thomas MH, Caetano C, Ross TM.
europepmc   +1 more source

Generation and Characterization of a CE1-Modified mCherry-Expressing Influenza A Virus for In Vivo Imaging and Antiviral Drug Evaluation. [PDF]

Viruses
Li Z, Liu M, Yang J, Sun Q, Ye D, Zhou W, Du R, Cheng S, Rong R, Yang Y, Liu X.   +10 more
europepmc   +1 more source

Severity of Clinical Presentation and Outcomes in Hospitalized Adult Patients with Influenza by Type and Subtype, United States-2017-2020. [PDF]

Clin Infect Dis
Cleary S, Lewis NM, Talbot HK, Zhu Y, Martin ET, Monto AS, Gaglani M, Murthy K, Zimmerman RK, Silveira FP, Tenforde MW, Patel MM, Ellington S, Olson SM.   +13 more
europepmc   +1 more source

Stimulation of Peripheral Blood Mononuclear Cells with <i>Lactococcus lactis</i> Strain Plasma Elicits Antiviral Effects Against H1N1 and SARS-CoV-2. [PDF]

Int J Mol Sci
Low ZX, Woo O, Kanauchi O, Hassandarvish P, Tiong V, AbuBakar S.   +5 more
europepmc   +1 more source

TMPRSS2 inhibitors with broad-spectrum efficacy against SARS-CoV-2 (JN.1) and influenza A (H1N1) viruses protect mice from influenza A infection. [PDF]

Emerg Microbes Infect
Presley L, Pérez-Vargas J, Saintigny A, Villanueva I, Ho M, Fone J, Brinsden L, Kaushik N, Olver S, Thompson CAH, Bautista-Sánchez D, Ennis S, Chen M, McCallum M, Brown JT, Ferková S, Hetrick B, Veesler D, Leduc R, Niikura M, Boudreault PL, Warner B, Jean F.   +22 more
europepmc   +1 more source